Mode
Text Size
Log in / Sign up

TCM and Integrated Medicine for Hyperuricemia: Umbrella Review Finds Superiority with Low CertaintyChinese Medicine Shows Promise for High Uric Acid, But Quality Issues Remain

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that evidence for TCM in hyperuricemia is low certainty and does not support definitive recommendations.

This umbrella review synthesized data from 11 systematic reviews examining Traditional Chinese Medicine (TCM) monotherapy and integrated Traditional Chinese and Western medicine (ITCW) for hyperuricemia. The population details were not reported within the source data. Comparators included Western medicine (WM) alone or placebo.

Regarding total effective rate, 8 SRs evaluated indicated TCM monotherapy and ITCW treatments were superior to Western medicine alone. For serum uric acid (sUA) levels, 10 SRs assessed showed TCM and ITCW regimens outperformed WM or placebo. Adverse reaction incidence was analyzed in 6 SRs analyzed, showing a lower incidence of adverse events with TCM and ITCW compared with WM.

Safety data indicated a lower incidence of adverse events with TCM and ITCW compared with WM. However, serious adverse events and discontinuations were not reported. Methodological quality of all included studies was rated as critically low. Limitations included lack of protocol registration and severe deficiencies in reporting quality.

The certainty of evidence for the majority of outcome measures was low or very low due to study limitations and inconsistency. Pooled results do not support definitive clinical recommendations due to critically low methodological quality. Clinicians should interpret these findings with caution given the evidence gaps.

Why you might feel stuck with high uric acid

High uric acid is a common health issue. It can lead to painful gout attacks and kidney stones. Many people take daily pills to lower their uric acid levels. But these standard drugs can sometimes cause side effects like stomach upset or skin rashes.

This leaves many patients searching for other options. Traditional Chinese Medicine (TCM) has been used for centuries. But does it really work for high uric acid? And is it safe?

A new review looked at all the existing research on this topic. The goal was to see if TCM helps lower uric acid and if it causes fewer side effects than Western medicine.

What we used to think about Chinese medicine

For a long time, many people have turned to herbal remedies. They often feel these natural treatments are gentler on the body. Doctors and patients alike have wondered if TCM could be a good alternative to standard drugs.

But without strong proof, it is hard to know for sure. In medicine, we rely on high-quality research to make decisions. This means looking at many studies together to get the clearest picture.

The surprising shift in the data

This new review looked at 11 different systematic reviews. These reviews combined data from many smaller studies. The goal was to see the overall effect of TCM for high uric acid.

The results were interesting. The review found that TCM, either alone or combined with Western medicine, seemed to work better than Western medicine alone. It helped more people lower their uric acid levels. It also seemed to cause fewer side effects.

But here’s the twist. The quality of the studies was very poor.

How the review worked

Researchers searched eight major medical databases. They looked for any systematic review about TCM for high uric acid published up to December 2025. They found 11 reviews that fit their criteria.

They then checked how well those reviews were done. They used standard tools to check the methods and the reporting. They also graded how much they could trust the results.

The review had three main findings.

First, TCM seemed to work well. Eight reviews looked at the overall success rate. They found that TCM and combined treatments were better than Western medicine alone. Ten reviews looked at uric acid levels. They also found TCM was better at lowering levels.

Second, TCM seemed safer. Six reviews looked at side effects. They found that TCM caused fewer adverse events than Western medicine.

But there is a big problem.

This is where things get tricky

The quality of the evidence was very low. All 11 reviews were rated as having "critically low" methodological quality. This means the way the original studies were done was not strong.

Many of the original studies did not register their plans beforehand. They also did not list which studies they left out. This makes it hard to trust the results.

The reporting was also poor. Many reviews did not clearly state who funded the study or if there were any conflicts of interest.

Why the quality matters so much

Think of it like building a house. If the foundation is weak, the whole house is shaky. In research, the methods are the foundation. If the methods are poor, the results are not reliable.

The review used the GRADE system to check the certainty of the evidence. For most outcomes, the certainty was low or very low. This means we cannot be confident in the findings.

What this means for high uric acid patients

So, what does this mean for you? It means there is hope, but we need better proof.

The review suggests TCM might help lower uric acid and reduce side effects. But the current evidence is not strong enough to recommend it as a standard treatment.

This doesn’t mean this treatment is available yet.

If you are interested in TCM for high uric acid, talk to your doctor. Do not stop taking your current medication without medical advice. Your doctor can help you weigh the risks and benefits.

The bigger picture

Experts agree that more research is needed. The current studies are not good enough to guide treatment. We need well-designed, large-scale trials. These trials should follow strict rules to ensure high quality.

Future research must be better. Scientists need to register their study plans before they start. They need to report their methods clearly. They need to be honest about funding and conflicts of interest.

Only then can we know for sure if TCM is a safe and effective option for high uric acid. Until then, the results are promising but not proven.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
ObjectiveThis study aimed to comprehensively evaluate the methodological quality, reporting quality, and certainty of evidence of systematic reviews (SRs) on Traditional Chinese Medicine (TCM) for hyperuricemia (HUA) using an umbrella review integrated with evidence mapping.MethodsSystematic searches were performed in PubMed, The Cochrane Library, Embase, Web of Science (WOS), CNKI, WanFang, SinoMed, and VIP to identify SRs evaluating TCM for HUA published up to December 2025. Methodological quality was assessed using the AMSTAR 2 tool, reporting completeness was evaluated according to the PRISMA statement, and the certainty of evidence for outcome measures was graded using the GRADE system.ResultsEleven SRs were ultimately included in the analysis. Eight SRs evaluated the total effective rate, demonstrating that both TCM monotherapy and integrated Traditional Chinese and Western medicine (ITCW) treatments were superior to Western medicine (WM) alone. Ten SRs assessed serum uric acid (sUA) levels, showing that both TCM and ITCW regimens outperformed WM or placebo. Six SRs analyzed adverse reaction incidence, demonstrating that the application of TCM and ITCW was associated with a lower incidence of adverse events compared with WM. The AMSTAR 2 assessment revealed that the methodological quality of all included studies was rated as critically low, with primary deficiencies being the lack of protocol registration and the failure to provide a list of excluded studies. The PRISMA evaluations showed a polarization in reporting quality, with severe deficiencies in key items such as protocol registration, funding disclosure, and conflict of interest reporting. The GRADE assessments indicated that the certainty of evidence for the majority of outcome measures was low or very low, primarily downgraded due to study limitations and inconsistency.ConclusionAlthough TCM and ITCW interventions showed potential benefits for favorable efficacy and safety in managing hyperuricemia, the pooled results are derived from studies of critically low methodological quality and therefore do not support definitive clinical recommendations. Existing systematic reviews suffer from poor methodological rigor and suboptimal reporting, highlighting an urgent need for standardized reporting guidelines. Future research should emphasize rigorous study design and mandatory protocol registration to generate high-quality evidence from well-conducted randomized controlled trials (RCTs).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.